Despite evidence of at least partial mediation by CB2, pretreatment with the CB1 inverse agonist, rimonabant, was able to fully reverse the anti-allodynic effects of 10 mg/kg ∆9-THC, highlighting the importance of CB1 receptors in a model of cisplatin-evoked neuropathy. The gene discussed is CNR2; the disease is neuropathy.